The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
90 jobs Number of planned job losses
Announcement Date
7 July 2014
Employment effect (start)
7 July 2014
Foreseen end date
Description
As announced on 7 July 2014, pharmaceuticals producer Actavis is to cut 90 jobs at its site in Weiterstadt. According to newspaper reports, the job cuts will make more than every fourth job redundant.
According to the management, job cuts were due to decreasing production. In Weiterstadt, Actavis prepares a drug against Crohn’s disease and packs a drug against osteoporosis. There is no information available on the end date of the measure.
All German and several Western European sites were acquired by Indian Aurobindo in January 2014. Originally from Island, Actavis is an international company with around 10,500 employees.
Sources
7 July 2014: FAZ
Citation
Eurofound (2014), Actavis, Internal restructuring in Germany, factsheet number 77318, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/77318.